Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
With tax day deadline here, Congress returned to Washington Monday to vote on the "Buffett Rule," a proposal to impose a minimum 30 percent tax on people earning more than $1 million.
The proposal, which failed in the Senate, resembles the alternative minimum tax (AMT) in one way -- it was...
American education doesn't need a few dozen superintendents gamely swimming against the tide, but tens of thousands of competent superintendents, principals, and administrators working in tandem.
TransAtlantic Business Dialogue Report to the US-EU Summit in Ireland, 26 June 2004
Establishing a Barrier-Free Transatlantic Market: Principles and Recommendations
Introduction and Executive Summary
A constructive and cooperative relationship between the United States and European Union is central to global security and...
Arthur Brooks and Jim Manzi are intellectual heirs to Hayek; they are admirably recapturing old truths handed down from America’s Founders and restating them for today’s generation.
Commentators tend to assume that the Japanese constitution's strict constraints on military activity form an insurmountable barrier to vigorous defensive cooperation. However, three upcoming events show that Tokyo can play a greater security role in the region without having to revise the constitution.
Tokyo is expected to announce Friday that it will buy America's F-35 Joint Strike Fighter (JSF), the clearest statement yet that Japan will not be left behind in Asia's arms race.
America's complete withdrawal of its troops from Iraq is a tragic mistake. It jeopardises the gains made by President Bush's (and Tony Blair's) eminently correct 2003 decision to overthrow Saddam Hussein, and risks the broader Middle East falling into chaos.
Reid Hoffman’s talk this week at Stanford (podcast and video available here) touched on several themes that collectively seem to comprise the Silicon Valley innovator ethos; most are relevant to healthcare and biopharma, and I agree with all his assertions except one.
(Hoffman, for...







